YERVOY conc perf 200 mg/40ml flac
7680617980020
CH-61798
L01FX04
07.16.1.
Reimbursement limitations:
YERVOY.01
Mélanome monothérapie
La monothérapie est remboursée lors de mélanomes avancés (non résécables ou métastatiques) chez …
1 / 3
google
Details
- Product number
- 6179802
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- ipilimumabum 200 mg, trometamoli hydrochloridum, natrii chloridum, mannitolum, acidum penteticum, polysorbatum 80, natrii hydroxidum aut acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 40 ml corresp. natrium 92 mg.
Articles (1)
YERVOY 200 mg/40 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
92.0 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 15354.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2012
Authorization holder
Bristol-Myers Squibb SA
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 61798
- Drug name
- YERVOY, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FX04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 14/10/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- YERVOY conc perf 200 mg/40ml flac
- Description (DE)
- YERVOY Inf Konz 200 mg/40ml Durchstf
- Market launch
- 14/10/2011
- Narcotic (BTM)
- No